Sort
326,823 grants matching “clinical trial”
Safety and Efficacy of Allogeneic Cardiosphere-derived Stem Cells After MI
$2,993,268Rachel Ruckdeschel Smith · Capricor, Inc. · RC3 · FY2010 · HL
INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH
$2,993,259Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2011 · RR
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,992,511Julianne L Imperato-McGinley · Weill Medical Coll Of Cornell Univ · UL1 · FY2009 · RR
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,992,416Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections-A5407 Third Supplement
$2,991,790Judith S. Currier · University Of California Los Angeles · UM1 · FY2025 · AI
Moffitt Cancer Center Support Grant
$2,990,966John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2020 · CA
Moffitt Cancer Center Support Grant
$2,990,966John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2021 · CA
Moffitt Cancer Center Support Grant
$2,990,966Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2018 · CA
Moffitt Cancer Center Support Grant
$2,990,966Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2017 · CA
Sample Collection and General Screening Protocols
$2,990,944Lesia K Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Heartland Cancer Research NCORP
$2,990,806Bryan Faller · Decatur Memorial Hospital · UG1 · FY2018 · CA
Clinical Research Center for the Improved Prevention, Diagnosis, and Treatment of Vocal Hyperfunction
$2,989,995Robert E Hillman · Massachusetts General Hospital · P50 · FY2023 · DC
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$2,989,362Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$2,989,268James E. Heubi · University Of Cincinnati · UL1 · FY2010 · RR
LEADERSHIP GROUP FOR ADOLESCENT MEDICINE TRIALS NETWORK
$2,988,964University Of Alabama At Birmingham · U01 · FY2002 · HD
Immunobiology and Immune Therapy for Merkel Cell Carcinoma
$2,988,939Paul Nghiem · University Of Washington · P01 · FY2021 · CA
Targets to Therapeutics in Pancreatic Cancer
$2,988,784Daniel D Von Hoff · Translational Genomics Research Inst · P01 · FY2006 · CA
Virginia Mason/UCHSC Autoimmune Prevention Center
$2,988,760University Of Colorado Denver · U19 · FY2003 · AI
CTN HEAL ENHANCEMENT. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. TO2. POP: 8/15/24 - 11/1/2026
$2,988,430Eve Jelstrom · The Emmes Company, Llc · N01 · FY2024 · DA
CANCER CENTER SUPPORT GRANT
$2,988,363Louis M Weiner · Georgetown University · P30 · FY2009 · CA
Development and Testing of Low Vision Assessment Tools for Retinal Prostheses.
$2,988,224Robert Jay Greenberg · Second Sight Medical Products, Inc. · RC3 · FY2010 · EY
Indiana Alzheimer's Disease Research Center
$2,988,197Andrew J Saykin · Indiana University Indianapolis · P30 · FY2023 · AG
Statistics Core for SWOG SDMC
$2,988,078Michael Leo Leblanc · Fred Hutchinson Cancer Research Center · U10 · FY2019 · CA
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,988,062Kathleen Theresa Brady · Medical University Of South Carolina · UL1 · FY2011 · RR
HIV-1 Therapy with CCR5 mAB PRO 140-Overview
$2,987,862William C Olson · Progenics Pharmaceuticals, Inc. · U19 · FY2008 · AI